European Archives - Page 1072 of 1469 - European Medical Journal

Causes and Impact of Cryopreservation-Associated Damage on Different Parameters of Human Spermatozoa and its Clinical Impact

The cryopreservation of gametes, as well as more complex multicellular organisms such as embryos, is an increasingly common practice in the field of…

Single Nucleotide Variations of Mitotic Arrest Deficient 1 Like 1 (MAD1L1) and MAD2L1 Genes in Products of Conception with Aneuploidy

Miscarriage is a pregnancy loss before the 20th week of the gestation. At least 15% of the recognised pregnancies will be terminated by spontaneous…

BESST, a Non-Invasive Computational Tool for Embryo Selection Using Mass Spectral Profiling of Embryo Culture Media

The current gold standard of embryo evaluation is based on morphology and morphokinetics, however there have been many efforts to design non-invasive…

Optimising the Outcome of Embryo Transfer

In vitro fertilisation (IVF) is a complex procedure, the success of which is dependent on several factors at every step of the process. Despite major advances, IVF implantation rates (IR) remain low and only a small percentage of patients achieve pregnancy.

To Analyse the Incidence of Ectopic Pregnancy in Fresh Embryo Transfer Compared with Frozen-Thawed Embryo Cycles in a Tertiary Infertility Centre in India

In vitro fertilisation (IVF) is one of the major risk factors for an ectopic pregnancy (EP). Rates of EP in women undergoing IVF range from 2–5%…

The Human Species-Specific Loss of the CMAH May Explain Our Predisposition to Cardiovascular Disease

One-third of the worldwide deaths relating to cardiovascular disease (CVD), such as heart attacks and strokes are due to the accompanying atherosclerotic…

Macrophages: The New Cardiac Healing Cells?

The heart, unlike other organs, has a very limited capacity to repair which considerably contributes to heart disease being the most prevalent cause of…

The European Medical Journal Presents: EMJ Hematology 2019

Detailing some of the most important topics in haematology, EMJ Hematology 7.1 is now available.

Cell therapy takeover

Over the past year investigation into cell therapies has grown markedly, with an estimated 80% increase; the US and China are taking the lead in the development of these therapies, with Europe the closest behind.

Tagraxofusp is a Novel Targeted Therapy Directed to CD123

Blastic plasmocytoid dendritic cell neoplasm (BPDCN), a rare, highly aggressive haematologic malignancy, often with cutaneous and other extramedullary…